| Item Type | Name |
|
Concept
|
Cancer-Associated Fibroblasts
|
|
Concept
|
Neoplasm Invasiveness
|
|
Concept
|
Neoplasm Metastasis
|
|
Concept
|
Neoplasm Proteins
|
|
Concept
|
Neoplasm Staging
|
|
Concept
|
Neoplasm Transplantation
|
|
Concept
|
Neoplasms
|
|
Concept
|
Neoplasms, Experimental
|
|
Concept
|
Pancreatic Neoplasms
|
|
Concept
|
Endometrial Neoplasms
|
|
Concept
|
Drug Resistance, Neoplasm
|
|
Concept
|
Tumor Cells, Cultured
|
|
Concept
|
Biomarkers, Tumor
|
|
Concept
|
Tumor Microenvironment
|
|
Concept
|
Tumor Burden
|
|
Concept
|
Cell Line, Tumor
|
|
Concept
|
Neoplasm Grading
|
|
Concept
|
Ovarian Neoplasms
|
|
Academic Article
|
Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells.
|
|
Academic Article
|
Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent.
|
|
Academic Article
|
MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer.
|
|
Academic Article
|
Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer.
|
|
Academic Article
|
Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer.
|
|
Academic Article
|
Inorganic nanoparticles in cancer therapy.
|
|
Academic Article
|
Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles.
|
|
Academic Article
|
Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle.
|
|
Academic Article
|
Probing novel roles of the mitochondrial uniporter in ovarian cancer cells using nanoparticles.
|
|
Academic Article
|
Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer.
|
|
Academic Article
|
MICU1 drives glycolysis and chemoresistance in ovarian cancer.
|
|
Academic Article
|
LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response.
|
|
Academic Article
|
MicroRNA-195 controls MICU1 expression and tumor growth in ovarian cancer.
|
|
Academic Article
|
Role of hedgehog signaling in ovarian cancer.
|
|
Academic Article
|
Sonochemically prepared BSA microspheres containing Gemcitabine, and their potential application in renal cancer therapeutics.
|
|
Academic Article
|
Effect of nanoparticle surface charge at the plasma membrane and beyond.
|
|
Academic Article
|
Efficient delivery of gold nanoparticles by dual receptor targeting.
|
|
Academic Article
|
Identifying new therapeutic targets via modulation of protein corona formation by engineered nanoparticles.
|
|
Academic Article
|
Role of cystathionine beta synthase in lipid metabolism in ovarian cancer.
|
|
Academic Article
|
MDR1 mediated chemoresistance: BMI1 and TIP60 in action.
|
|
Academic Article
|
Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth.
|
|
Academic Article
|
BMI1, a new target of CK2a.
|
|
Academic Article
|
Cystathionine ß-synthase regulates mitochondrial morphogenesis in ovarian cancer.
|
|
Academic Article
|
Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro.
|
|
Academic Article
|
Gold nanoparticles inhibit activation of cancer-associated fibroblasts by disrupting communication from tumor and microenvironmental cells.
|
|
Academic Article
|
Experimental conditions influence the formation and composition of the corona around gold nanoparticles.
|
|
Academic Article
|
Antiangiogenic properties of gold nanoparticles.
|
|
Academic Article
|
Biological properties of "naked" metal nanoparticles.
|
|
Academic Article
|
Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis.
|
|
Academic Article
|
A core-shell nanomaterial with endogenous therapeutic and diagnostic functions.
|
|
Academic Article
|
A simple synthesis of a targeted drug delivery system with enhanced cytotoxicity.
|
|
Academic Article
|
Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo.
|
|
Academic Article
|
Switching the targeting pathways of a therapeutic antibody by nanodesign.
|
|
Academic Article
|
Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance.
|
|
Academic Article
|
Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles.
|
|
Academic Article
|
Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer.
|
|
Academic Article
|
Evaluating the Mechanism and Therapeutic Potential of PTC-028, a Novel Inhibitor of BMI-1 Function in Ovarian Cancer.
|
|
Academic Article
|
Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer.
|
|
Academic Article
|
Nanoparticle Interactions with the Tumor Microenvironment.
|
|
Academic Article
|
Gold Nanoparticles sensitize pancreatic cancer cells to gemcitabine.
|
|
Academic Article
|
Ubiquitin-binding associated protein 2 regulates KRAS activation and macropinocytosis in pancreatic cancer.
|
|
Academic Article
|
Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human cancer cells using cetuximab-targeted gold nanoparticles.
|
|
Academic Article
|
Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancer.
|
|
Academic Article
|
Cancer nanotechnology: emerging role of gold nanoconjugates.
|
|
Academic Article
|
Inhibiting the growth of pancreatic adenocarcinoma in vitro and in vivo through targeted treatment with designer gold nanotherapeutics.
|
|
Academic Article
|
Understanding protein-nanoparticle interaction: a new gateway to disease therapeutics.
|
|
Academic Article
|
Hepatoma derived growth factor (HDGF) dynamics in ovarian cancer cells.
|
|
Academic Article
|
Inhibition of BMI1 induces autophagy-mediated necroptosis.
|
|
Academic Article
|
Gold Nanoparticles Disrupt Tumor Microenvironment - Endothelial Cell Cross Talk To Inhibit Angiogenic Phenotypes in Vitro.
|
|
Academic Article
|
Gold Nanoparticle Transforms Activated Cancer-Associated Fibroblasts to Quiescence.
|
|
Academic Article
|
KRCC1: A potential therapeutic target in ovarian cancer.
|
|
Academic Article
|
Switching the intracellular pathway and enhancing the therapeutic efficacy of small interfering RNA by auroliposome.
|
|
Grant
|
Development of a gold nanoparticles based targeted delivery system
|
|
Grant
|
Molecular Mechanism of Antiangiogenic Properties of Gold Nanoparticle
|
|
Grant
|
UBAP2, A New Molecule in Pancreatic Cancer Progression
|
|
Grant
|
Reprogramming Tumor Microenvironment by Nanoparticle
|
|
Grant
|
Normalizing aberrant metabolism in ovarian cancer by a unique drug delivery system
|
|
Academic Article
|
Improved pentamethine cyanine nanosensors for optoacoustic imaging of pancreatic cancer.
|
|
Academic Article
|
Small Non-Coding-RNA in Gynecological Malignancies.
|
|
Academic Article
|
Synergistic interventional photothermal therapy and immunotherapy using an iron oxide nanoplatform for the treatment of pancreatic cancer.
|
|
Academic Article
|
Active Targeting Significantly Outperforms Nanoparticle Size in Facilitating Tumor-Specific Uptake in Orthotopic Pancreatic Cancer.
|
|
Academic Article
|
Unraveling Autocrine Signaling Pathways through Metabolic Fingerprinting in Serous Ovarian Cancer Cells.
|
|
Academic Article
|
Patient-Derived Xenografts of High-Grade Serous Ovarian Cancer Subtype as a Powerful Tool in Pre-Clinical Research.
|